Last reviewed: June 22, 2026
Last updated: June 22, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, originally developed for type 2 diabetes, has become one of the most researched medications for weight loss after multiple clinical trials showed participants losing 15-22% of their body weight. Unlike fixed-dose medications, semaglutide therapy uses a gradual titration schedule where your dose increases over time to reach the level that works best for your metabolism and goals. Understanding how dosing progresses and why it matters can help you make informed decisions about your weight loss treatment.
Typical Semaglutide Weight Loss Dosing Schedule
Semaglutide weight loss treatment begins with a starter dose of 0.25 milligrams once weekly, a dose low enough to let your body adjust to the medication while minimizing nausea and gastrointestinal side effects. Over the following four weeks, your healthcare provider gradually increases your dose by 0.25 mg increments—moving to 0.5 mg in week two, 0.75 mg in week three, and 1.0 mg in week four. This controlled escalation is called titration, and it allows your body to build tolerance while your appetite-suppressing response activates.
Most patients find their therapeutic sweet spot somewhere between 1.0 mg and 2.4 mg per week, though individual responses vary significantly based on body composition, metabolic rate, and genetic factors affecting how your body processes GLP-1 receptor signals. Once you reach a dose that controls hunger effectively and produces steady weight loss, you typically remain on that maintenance dose rather than continuing to increase indefinitely. The titration phase usually takes 16-20 weeks to complete, though some patients stabilize sooner while others benefit from a slower progression with longer intervals between increases.
How Semaglutide Creates Weight Loss at Different Doses
Semaglutide works by mimicking glucagon-like peptide-1 (GLP-1), a natural hormone that signals fullness to your brain and slows how quickly food leaves your stomach. At lower starting doses (0.25-0.5 mg), the primary effect is mild appetite suppression and slight improvements in blood sugar control, with many patients reporting they feel satisfied with smaller meal portions. As doses climb toward 1.5-2.4 mg, the medication's impact deepens—hunger hormones drop more significantly, cravings diminish, and your body's energy expenditure may increase slightly, creating the metabolic conditions needed for consistent fat loss.
The dose-response relationship isn't linear, meaning doubling your dose doesn't produce double the weight loss. Instead, research shows that weight loss improvements plateau somewhere between 1.5 mg and 2.4 mg for most people, suggesting that going higher than 2.4 mg provides diminishing returns while potentially increasing side effect risk. Your ideal dose is the lowest amount that delivers meaningful appetite control and steady weight loss without side effects that interfere with daily life—this is why personalized titration matters far more than chasing the highest available dose.
Why Personalized Dosing Beats One-Size-Fits-All Approaches
Two people weighing the same amount can respond very differently to identical semaglutide doses due to differences in GLP-1 receptor sensitivity, metabolic rate, liver function, and genetic variations in the genes controlling appetite pathways. Someone with a highly responsive GLP-1 receptor may achieve excellent results at 1.0 mg weekly, while another person with lower receptor sensitivity might need 2.0 mg to reach the same hunger-suppression level. Genetic testing can now reveal these predispositions—PlexusDx offers the Precision Peptide Genetic Test to analyze key variants like GLP1R rs6923761 and other peptide-pathway genes that influence how your body responds to semaglutide.
By understanding your genetic profile, PlexusDx healthcare providers can predict which dose range is most likely to work for you and avoid the trial-and-error cycle that wastes time and medication. This precision approach means you may reach your goal dose faster, experience fewer unwanted side effects, and achieve better long-term weight loss outcomes. PlexusDx compounded semaglutide injections start at $149 per month regardless of your current dose—your dose may need to go up, but your price won't increase as you titrate upward.
Managing Side Effects While Finding Your Optimal Dose
Nausea, vomiting, and constipation are the most common side effects during the titration phase, typically peaking a few days after each dose increase and fading within 7-10 days as your digestive system adapts. Starting at the lowest dose (0.25 mg) and increasing slowly gives your body time to adjust, which often reduces the intensity and duration of nausea compared to faster titration schedules. If side effects become severe, your provider can pause increases for an extra week or two, allowing more time for adaptation before moving to the next dose level.
Staying well-hydrated, eating smaller meals, avoiding fatty foods, and getting adequate fiber intake can significantly lessen gastrointestinal symptoms during titration. If side effects persist or worsen despite these strategies, your healthcare provider may recommend staying at your current dose longer or may explore whether a different delivery method (like oral semaglutide) might suit you better. The goal is finding a dose that balances effective weight loss with a side-effect profile you can comfortably tolerate long-term.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the minimum effective dose of semaglutide for weight loss?
Most patients begin seeing meaningful weight loss at 0.5-0.75 mg weekly, though some experience appetite suppression at the starter dose of 0.25 mg. However, the dose that works for you depends on your individual metabolism and GLP-1 receptor sensitivity—the Precision Peptide Genetic Test can help identify your likely response pattern before you start titrating.
Will my semaglutide dose keep increasing forever?
No. Titration continues until you reach a maintenance dose that produces steady weight loss and manageable side effects—typically between 1.0 mg and 2.4 mg weekly. Once you find that dose, you remain on it long-term rather than continuing to increase indefinitely, making long-term treatment predictable and affordable.
How much does semaglutide cost at PlexusDx, and does price change with dose?
PlexusDx compounded semaglutide injections from licensed 503A pharmacies start at $149 per month—that price stays the same whether you're at 0.25 mg or 2.4 mg. There's no flat per-compound pricing, no membership fee, and treatment is available in all 50 states with HSA/FSA eligibility.
Is higher-dose semaglutide more dangerous or cause more side effects?
Higher doses do carry slightly increased nausea risk during titration, but serious adverse events remain rare when titration is gradual and supervised. Most side effects are mild-to-moderate and manageable with dietary adjustments and time—your provider can slow your titration schedule if you need more adaptation time between dose increases.
How can I know if my semaglutide dose is too high or too low?
Your dose is too low if you're not experiencing appetite suppression or seeing weight loss after 4-6 weeks of treatment. Your dose may be too high if you're experiencing persistent nausea, vomiting, or constipation that interferes with eating and hydration. The PlexusDx Precision Peptide Genetic Test identifies genetic predispositions in GLP1R, GIPR, FTO, and MC4R genes that influence your likely optimal dose range, helping your provider dial in the right amount faster.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Your Health: Can Metformin Be Taken with Zepbound?
How to Give a Wegovy Injection: A Comprehensive Guide